Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by University of Vermont
Sponsor:
Collaborators:
Michael J. Fox Foundation for Parkinson's Research
Parkinson Study Group (PSG)
International Parkinson Fonds (IPF)
German Parkinson Study Group (GPS)
German Parkinson Society (DPG)
Information provided by (Responsible Party):
James BOYD MD, University of Vermont
ClinicalTrials.gov Identifier:
NCT01560754
First received: March 9, 2012
Last updated: July 23, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)